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Abstract
This chapter explores the efficacy of psychotherapeutic interventions for
patients with type 2 diabetes mellitus (T2DM). This condition can lead to serious
adverse health outcomes (e.g., cardiovascular disease, blindness, loss of limbs, etc.).
Medical interventions alone are often not sufficient to manage the disease. Psycho-
therapy can promote behavioral change that improves medication adherence, die-
tary choices, exercise, stress, and other variables that affect blood sugar levels. The
current chapter summarizes the trends in recent research for psychotherapeutic
interventions for the management of T2DM. The results from 16 randomized con-
trolled trials on cognitive-behavioral therapy, motivational interviewing, counsel-
ing, and mindfulness-based therapies are discussed. These interventions varied in
length (3 to 18 months) and were conducted in many geographic regions (e.g.,
Australia, Netherlands, Saudi Arabia, Thailand, and more). Changes in biological
health outcomes (i.e., HbA1c levels) were the primary focus of this chapter, but
diabetes-related behavioral changes (e.g., diet and exercise) and psychological vari-
ables (e.g., stress, depression, and well-being) are also discussed. This chapter
highlights that recent research has provided the most support for mindfulness-
based therapies for improving blood sugar levels in patients with T2DM.
Keywords: Type 2 diabetes mellitus, psychotherapy, intervention, diet, exercise
1. Introduction
Diabetes mellitus is a condition marked by an inability to produce or properly
use insulin, a hormone that allows cells to use glucose for energy [1]. Approximately
3 million Canadians, or 8% of the general population, are living with diabetes, with
the prevalence increasing with age [1]. The condition usually develops in middle
aged or older adults, and men are slightly more likely to be diagnosed with this
condition (8.7%) than are women (7.6%) [1]. There are two types of diabetes
mellitus: type 1, where the body cannot produce a sufficient amount of insulin, and
type 2, where the body cannot use the insulin it produces effectively, resulting in
high blood sugar levels [1]. Accordingly, blood glucose levels are the most reliable
physiological marker by which to diagnose diabetes mellitus [2] and are also used to
monitor patients’management of their condition. The main criterion for a diagnosis
of diabetes mellitus is a hemoglobin A1c [HbA1c] level above 6.4%, indicating
above-average blood sugar levels, for the past 2–3 months. Interventions that pro-
duce lower HbA1c levels indicate efficacy at improving patient self-management of
their diabetes mellitus. If left untreated or if poorly managed, diabetes mellitus can
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lead to serious health conditions such as heart disease and stroke, blindness, nerve
damage, and loss of limbs [1].
About 90% of people with diabetes mellitus have type 2 (T2DM). This is a
chronic disease, which must be carefully managed on an ongoing basis by the
patient and/or their caregivers. The biopsychosocial approach combines the use of
medication and insulin with self-management behaviors for the purpose of regulat-
ing blood glucose levels. Lifestyle changes that are generally recommended for
people at higher risk of diabetes and those who are newly diagnosed include suffi-
cient moderate to high intensity exercise, and dietary considerations such as
increased intake of fiber and reduced intake of fats (especially saturated fat). As
well, overweight individuals are advised to lose weight gradually to achieve a body
mass index in the healthy range. Health care professionals working with patients
with T2DM aim to teach and encourage appropriate eating habits and physical
activity to help patients achieve better glycemic control. However, implementing
and adhering to these lifestyle changes is often difficult. Many individuals with
T2DM do not adhere to the recommended nutrition and physical activity guidelines.
Specifically, many patients exceed the recommended fat and sodium intake, and do
not consume enough grains, dairy, fruits and vegetables [3]. Stress is also recog-
nized as a variable that can exacerbate T2DM. Stress triggers the release of hor-
mones that produce a surge in blood glucose levels. For this reason, stress
management is considered to be part of a biopsychosocial approach to the manage-
ment of T2DM. Due to the prevalence and manageability of this type of diabetes
mellitus through lifestyle modifications alone, this chapter will focus solely on
T2DM.
In addition to pharmacological interventions, various psychotherapeutic inter-
ventions are used and have been studied to help people with T2DM achieve better
glycemic control. In theory, psychotherapy can promote behavioral changes that
would improve medication adherence, dietary choices, exercise, stress levels, and
other variables that affect blood sugar levels. Within this chapter, we review various
psychotherapeutic interventions that are commonly used for the management of
T2DM, including cognitive-behavioral therapy, motivational interviewing,
counseling, and mindfulness-based therapies. This chapter explores the trends in
recent research to understand the evidence base for various psychotherapeutic
interventions in the management of T2DM. Change in HbA1c level is the primary
focus of this chapter, since HbA1c is commonly measured and is the most objective
and standardized outcome measure across studies. However, trends in diabetes-
related behavioral changes (e.g., diet and exercise) and psychological variables
(e.g., coping, stress, depression, and well-being) are also discussed.
2. Psychotherapeutic interventions for type 2 diabetes mellitus
Previous review papers have demonstrated that psychotherapeutic interventions
in general are effective at improving health outcomes for individuals with T2DM. A
2004 meta-analysis of 12 randomized control trials (RCT) of psychological inter-
ventions (i.e., cognitive behavior therapy, counseling, or psychodynamic therapy)
found lower HbA1c levels and psychological distress compared to different control
groups (i.e., treatment as usual, an education group, attentional control, or waitlist
control) [4]. There was no difference between treatment groups on weight gain and
blood glucose concentration, suggesting that there was no clearly superior psycho-
logical intervention for the management of T2DM. A 2013 systematic review simi-
larly concluded that psychotherapy is effective in supporting healthy coping among
individuals with diabetes mellitus [5]. More recently, a 2020 meta-analysis of 70
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RCTs found that psychological interventions, such as cognitive behavioral therapy,
self-help materials, and counseling, were generally effective in reducing HbA1c
levels over and above usual care [6].
These research findings cited above support the general use of psychotherapeu-
tic interventions in the management of diabetes mellitus. However, it would be
helpful to know whether and how specific interventions can enhance care for
patients with T2DM so as to assist with treatment planning. In this chapter we
analyze the recent literature on the efficacy of psychotherapeutic interventions for
the care of T2DM. There have been 16 relevant RCTs published within the past
8 years (see Appendix A for details of the search strategy), which represent the
most up-to-date published scientific findings on the topic. These studies and time
period were deemed to give a valid snapshot of the recent literature. The results of
specific studies are discussed, and we summarize the most noteworthy findings
within each type of psychotherapeutic intervention. The effects of specific inter-
ventions on various outcomes relevant to patients with T2DM are discussed in
detail. See Table 1 for a summary of the reviewed studies.
2.1 Cognitive-behavioral therapy
Cognitive-behavioral therapy (CBT) is an umbrella term that encompasses var-
ious cognitive and behavioral techniques to identify and transform negative think-
ing patterns. CBT has been used to promote behavioral change in patients with
diabetes mellitus [7]. A goal of CBT is to help individuals understand barriers to
their own diabetes mellitus self-management and to provide them with the skills
necessary to cope with these barriers. For example, a patient with diabetes mellitus
may think, “I have a terrible chronic condition and there is nothing I can do about
it.” This type of cognition can lead to poor treatment adherence, low confidence,
and/or high levels of stress. Within a CBT protocol, the therapist helps the patient to
identify thinking errors or “cognitive distortions” (e.g., anticipating the worst out-
come, focusing on the negative, and thinking in all-or-nothing terms) and to use
strategies to challenge these beliefs (e.g., “what evidence is there for and against this
thought?”). In addition to developing more balanced or rational thoughts, the ther-
apist and the patient can also work on behavioral changes. They may engage in
gradual exposure to challenging activities (e.g., walking for 5 minutes a day, then
10 minutes, then 20 minutes, until they can walk for one hour) or behavioral
experiments (e.g., writing down how they feel before and after taking medication in
order to help identify that anticipatory anxiety is often worse than any discomfort
they feel during or after the avoided task). In CBT, patients receive emotional and
psychological support while learning strategies to overcome avoidance and to
adhere to their medication, dietary intake, and physical activity goals. CBT for the
management of T2DM can be done in weekly individual or group sessions, and is
traditionally done in-person with a therapist and over the span of several weeks to
months.
For many years, CBT was the most commonly investigated form of psychother-
apy for T2DM (for example, see [4–6]) and results confirmed its efficacy in
increasing positive outcomes. In recent years, the literature has shifted away from
investigating CBT in its traditional application. Instead, new research has begun to
examine CBT in alternative delivery formats in an effort to boost accessibility. For
instance, a 6-month web-based CBT intervention was found to be more effective
than a control group in lowering HbA1c levels (p = .002) among T2DM patients in
Saudi Arabia [8]. It also resulted in better diabetes mellitus knowledge (p = .004)
and self-efficacy (p < .001) relative to a control group, suggesting that CBT can
produce a meaningful change in cognitions that are related to successful self-
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Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Abu-Saad, Murad, Barid,
Olmer, Ziv, Younis-Zeidan, &
Kalter- Leibovici (2019)
50 53 21,29 Arab Israel Interactive lifestyle assessment, counseling














Alanzi, Alanzi, Istepan i-an, &
Philip (2018)
20 NA 15,5 NA Saudi
Arabia
Mobile CBT 6 months Biological
Conventional diabetes treatment HbA1c .002
Diabetes-related
Diabetes Knowledge Test .004
Psychological




60 56 11, 49, NA Iran Mindfulness-based stress reduction 3 months Biological
HbA1c .01
Fasting blood sugar .001
Usual care Psychological

























Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Chee, Gilcha-ran Singh,
Hamdy, Mechanick, Lee, Barua,
Ali & Hussein (2017)
230 55 85, 145 Indian (58%) Malaysia Motivational interviewing (Trans-cultural
diabetes-specific nutrition algorithm+MI)








Weight loss < .001
Body Mass Index < .001
Conventional counselling (Trans-cultural
diabetes-specific nutrition algorithm+CC)
Waist circumference < .001
Body fat < .001
Fasting plasma glucose .027
Systolic blood pressure .003
Diastolic blood pressure .013
Total

















































Author (Year) N Age Sex
(M, F)








Pollmann, Fairn, Raspe &
Mittag (2018)
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Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Friis, Johnson, Cutfield, &
Consedine (2016)
63 43 20, 43 New Zealand New
Zealand




Maori (2%) Self-Compassion .05
Depression .001







Tanaka & Suksom (2016)
23 60 4, 19 NA Thailand Traditional walking 3 months Biological
Walking meditation HbA1c < .05













































Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Holmen, Torbjornsen, Wahl,
Jenum, Smastuen, Arsand, &
Ribu (2014)
151 57 89, 62 NA Norway Few Touch Application (FTA) 12
months
Biological
HbA1c (FTA x control) .42Few Touch Application—Health Counseling
(FTA-HC)!Motivational interviewing
Control

















van der Weijden, Elwyn & Grol
(2013)




Systolic blood pressure .279





























Author (Year) N Age Sex
(M, F)
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controlled motivation
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Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Mohamed, Al-Lenjawi, Amuna,
Zotor, & Elmahdi (2013)





Problem Areas in Diabetes .31
Mental component of the








Fasting plasma glucose .022
Total cholesterol .204
High-density lipoproteins < .001
Low-density lipoproteins .203
Triglyceride .200
Albumin/creatinine ratio < .001
Systolic blood pressure .631
Diastolic blood pressure .421



























Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Pearson, Wills, Woods, &
Warnecke (2018)
67 59 36, 31 NA Australia Mindfulness practice 3 months Biological
Usual care HbA1c .02
Monitoring Blood Glucose . 06
Systolic blood pressure .78









Problem Areas in Diabetes .78


























































Author (Year) N Age Sex
(M, F)







Anxiety - GAD-7 (MBCT x
Control)
.004
Anxiety - GAD-7 (CBT x
Control)
.01
Diabetes Distress (MBCT x
Control)
.02
Diabetes Distress (CBT x
Control)
.04
van Son, Nyklicek, Pop, Blonk,
Erdtsieck, Spooren, …Pouwer
(2013)
139 56.5 70, 69 NA Netherland Mindfulness-based cognitive therapy 3 months Biological
HbA1c .35
Usual care Diabetes-related
Physical Health Status .03
Psychological





























Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
van Son, Nyklicek, Pop, Blonk,
Erdtsieck, & Pouwer (2014)
139 56.5 70, 69 NA Netherland Mindfulness-based cognitive therapy 6 months Biological
HbA1c .816Usual care
Diabetes-related























Usual care HbA1c >.05
Blood sugar >.05
Body mass index >.05





































Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Diastolic blood pressure >.05
Diabetes-related
Problem areas in diabetes >.05
Diabetes self-care activities >.05












Body mass index >.05
Systolic blood pressure >.05
Diastolic blood pressure >.05
Diabetes-related






















Author (Year) N Age Sex
(M, F)
Ethnicity Country Intervention Duration Outcome p-value
Diabetes self-care activities >.05
Healthy diet >.05
Physical activity >.05
Diabetes medication < .01





Note. NA = Not available within the article.
aWithin group differences
Table 1.





































management of the condition. Internet-based CBT protocols offer a promising and
accessible psychotherapeutic intervention for T2DM patients, but more randomized
controlled trials are needed to further elucidate their efficacy. It is also possible that
certain patients will do better than others with web-based CBT interventions.
Therefore, treatment matching trials are needed to identify the personal character-
istics that best predict positive outcomes with non-traditional formats of CBT for
T2DM.
2.2 Motivational interviewing
Motivational interviewing (MI) is a collaborative and goal-oriented therapy that
focuses on resolving ambivalence toward change [9]. Suggestions or instructions for
diabetes mellitus self-management may be met with resistance and non-compliance
by patients. MI counters these responses by promoting self-efficacy. The therapist
helps the patient to determine what is important to their own well-being and how to
achieve that goal [10]. For example, a therapist may explore what the patient likes
and does not like about their current behaviors to determine the costs and benefits
of behavior change. By putting the patient in the ‘driver’s seat’, intrinsic motivation
is developed (e.g., “I will change my diet and exercise because I want to live a long
and healthy life”). The therapeutic alliance is seen as fundamental to facilitating
positive behavior change. From this starting point, the therapist and patient can
work together to set an agenda for items they would like to change (e.g., medica-
tion, diet, exercise, and regular monitoring of blood sugar levels) and check in
frequently about the patient’s perceived importance and confidence regarding the
target behavior [10].
Although MI has garnered a lot of research interest, the results of recent studies
examining its utility in the management of T2DM have been mixed. In support of
this intervention in the care of T2DM, Chee and colleagues (2017) found that
patients who received MI for 6 months, in addition to diet and exercise planning,
reported greater reductions in HbA1c (p = .006) and weight loss (p < .001) than a
control group at 6 month follow up [11]. This study took place in Malaysia with a
sample of 230 Indian (58%), Chinese (28%), and Malaysian (14%) participants,
aged 30–65 years (M = 55, SD = 8). However, a number of recent studies have not
found support for MI over treatment as usual. For example, patients treated by
nurses trained in MI in the Netherlands and Denmark had similar HbA1c levels,
diet, physical activity, and well-being as those treated by nurses trained in standard
care. This pattern of results was found in both 14- and 18-month trials [12, 13].
Notably, the competency of the nurses trained in psychological skills for that study
was below beginner-level proficiency and was similar to the standard-care nurses.
In other words, it may require extensive training among therapists in order to
demonstrate the superiority of MI over control groups.
Recent findings for MI in the management of T2DM are also mixed when MI
examined in alternative delivery formats. A 12-month telephone-based delivery of
MI in Germany was found to reduce patients’ HbA1c levels to a greater extent than
usual care (i.e., informational pamphlets; p = .006). It also improved to a greater
extent patients’ physical activity (p = .006), cardiovascular health (p = .011), psy-
chological well-being (p = .044), illness burden (p = .069), and depression
(p = .057) [14]. In another study from Norway, telephone-based MI was provided
for 4 months in addition to an interactive mobile self-monitoring application that
tracks diet, fitness, and diabetes-related goals. There were no differences in
patients’ HbA1c levels between app users with and without MI, or those who
received usual care (i.e., no psychotherapeutic intervention) [15], suggesting that
neither the app nor the MI produced a better health outcome than standard, non-
16
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psychotherapeutic care. Similarly, a 6-month web-based counseling software deliv-
ery of MI was equivalent to standard lifestyle advice in resulting HbA1c levels
among Arab participants [16]. The MI-based intervention was, however, superior to
the control group at increasing short-term diabetes-related knowledge (p = .023)
among patients and trended toward within group improvements in dietary habits
(p = .050). The discrepancy between the findings within that study further high-
light that all MI delivery formats are not equal; long-term direct therapist contact
may be an essential component of MI in order to elicit sufficient behavior change
that manifests in reductions in HbA1c levels. Further research would be necessary
to confirm this hypothesis.
2.3 Counseling
Another category of psychological interventions for T2DM involves counseling
interventions which tend to provide non-specific support for diabetes mellitus
management. Counseling typically promotes self-awareness and self-determination
which, in the context of diabetes mellitus, can aid in improving self-management
behaviors [17]. Counseling can also provide emotional and psychological support to
individuals who are dealing with the stress of living with a chronic disease. In other
words, although behavior change is not the focus of counseling interventions, they
may, in theory, be helpful for reducing stress and increasing adherence among
patients.
RCTs of counseling interventions for T2DM are scarce [4–6], but there have
been two recent studies on this modality. One study examined a culturally sensitive
12-month counseling program for T2DM patients in Qatar (i.e., using Arabic lan-
guage and referencing culturally specific food habits and health beliefs). Within this
program, patients were provided with information about diabetes and related com-
plications, how to incorporate a healthy lifestyle and eating habits, the benefits of
exercise, and how to use counseling techniques at home. The researchers found that
this program led to significant reductions in patients’ HbA1c levels (p = .012) and
BMI (p < .001), as well as improved diabetes-related knowledge (p < .001), atti-
tudes (p < .001), and practices (p < .001) over the standard practice of distributing
informational booklets [18]. However, in another study of counseling, patients in
Denmark who were offered short-term empowerment, motivation and medical
adherence (EMMA) therapy, which focuses on goal setting and autonomy support,
did not report improvements in HbA1c levels over and above treatment as usual.
Individuals who received counseling did, however, demonstrated increases in fre-
quency of healthy eating (p < .05) [19].
Based on these findings, counseling may have benefits for improving HbA1c
levels in specific cultural contexts, but these therapies may have to be long-term
(one year or longer) and follow a structured format to be beneficial for glycemic
control.
2.4 Mindfulness-based therapies
Mindfulness-based therapies teach meditative practices and promote a non-
judgmental awareness of the present moment, including noticing thoughts, emo-
tions, and bodily sensations. In the context of T2DM, noticing negative diabetes-
related thoughts can help promote passive observation of the experience and allow
the individual to be present in their everyday life without an unhelpful behavioral
reaction. For example, noticing internal hunger or satiety cues can influence dietary
choices and help patients regulate blood sugar levels. Mindfulness can, in theory,
help patients become better attuned to their physiological state, including blood
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sugar levels. Or a patient who experiences anxiety about increasing their physical
activity may learn to nonjudgmentally notice their anxious thoughts and urges to
avoid exercise, but intentionally choose to exercise nonetheless. Regular mindful-
ness practice trains the mind to be less reactive and more intentional in one’s choices
and experiences.
Mindfulness interventions have increased in popularity in the past decade and
there have been a number of recent RCTs that indicate the applicability of
mindfulness-based therapies for the treatment of diabetes mellitus. The outcomes
are mixed in regard to changes in HbA1c levels. In support of the efficacy of
mindfulness programs, an 8-week mindfulness-based stress reduction program in
Iran was found to improve HbA1c levels (p = .010), fasting blood sugar (p < .001),
depression (p = .010), anxiety (p = .010), and overall mental health (p = .001)
compared to a control group [20]. In another study from New Zealand, an 8-week
program based in mindful self-compassion led to greater decreases in HbA1c
(p = .050) than a waitlist control, as well as reductions in depression (p = .001) and
diabetes-related distress (p = .050) [21]. Even when the 8-week program was self-
directed, mindfulness practice has been found to improve HbA1c levels (p = .020),
stress (p = .030), and depression symptoms (p = .020) compared to a control
condition in Australia [22]. Specific techniques within a mindfulness-based practice
have been found to be effective. For instance, Thai patients with T2DM who
engaged in mindful walking for 3 months demonstrated greater decreases in HbA1c
(p < .050) relative to walking alone [23].
A relatively recent variation of mindfulness therapy, mindfulness-based cogni-
tive therapy, involves training patients in both meditation and cognitive therapy
(i.e., identifying and challenging cognitive distortions). A series of studies in the
Netherlands were recently conducted to investigate the effects of this intervention
on the care of patients with T2DM, but none showed any benefit for HbA1c levels.
For instance, although van Son and colleagues [24, 25] found improvements in self-
reported stress (p = .001), anxiety (p = .020), depression (p = .010), and improved
quality of life (p = .010) following mindfulness-based cognitive therapy and that
were maintained at 6-month follow-up, they did not find a difference on HbA1c
levels when compared to usual care. Another study also did not find differences in
glycemic control between mindfulness-based cognitive therapy and a control
group, but did report changes in diabetes-related distress (p = .020) and well-being
(p = .001) [26]. Within these studies, poor glycemic control was not an inclusion
criterion, which may have resulted in a floor effect due to generally low levels
among patients regardless of treatment condition. It may be that mindfulness-based
cognitive therapy, which was originally developed to treat depression, is less effec-
tive at reducing HbA1c levels than traditional mindfulness training practices that do
not incorporate cognitive therapy but focus instead on meditation. In other words,
the cognitive therapy addition may dilute the efficacy of mindfulness training,
which, at this point in time, has more support for it in the care of T2DM. Research
designs that compare mindfulness-based cognitive therapy to other mindfulness
interventions in patients with poor glycemic control would be necessary to confirm
this hypothesis.
3. Summary
T2DM is a serious disease with significant morbidity which, if poorly managed,
can lead to short- and long-term complications including cardiovascular disease,
blindness, nerve damage, and loss of limbs [1]. There has been interest among
researchers to examine whether psychotherapeutic interventions aimed at changing
18
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thoughts, feelings, and/or behaviors among patients with T2DM have any signifi-
cant benefit. Recent randomized controlled trials suggest that psychotherapy for
T2DM may be an effective treatment option for certain outcomes, but that not all
therapies have an evidence base for use with patients with T2DM.
Research from the past 8 years has provided the most support for mindfulness-
based therapies at improving health outcomes for patients with T2DM. Numerous
studies with different samples have demonstrated statistically significant reductions
in HbA1c levels and fasting blood sugar, as well as improvements in psychological
variables such as depression, anxiety, stress, diabetes-related distress, and overall
mental health. These findings were demonstrated in various geographical regions
(including Iran, New Zealand, and Australia) among middle-aged (average age
ranged from 23 to 59 years old) men (n = 67) and women (n = 123). Notably,
however, mindfulness-based cognitive therapy was only superior to a control group
for psychological outcomes, not HbA1c levels. In other words, mindfulness-based
therapies that emphasize meditative practices, but not mindfulness-based cognitive
therapy, have evidence to support their use in the management of T2DM. Of note,
the existing studies on mindfulness-based cognitive therapy that did not show its
benefit for glycemic control were conducted with middle-aged (53 to 56.5 years old)
men (n = 118) and women (n = 115) from the Netherlands. As such, this form of
therapy may not be effective within this relatively young sample. More research is
needed to understand whether mindfulness-based cognitive therapy is as good or
better than mindfulness therapy.
While research interest in traditional-delivery CBT has declined in recent years,
one recent study expanded upon existing literature to demonstrate the effectiveness
of CBT in a web-based format in diabetic patients from Saudi Arabia. This program
improved HbA1c levels, as well as diabetes mellitus knowledge and self-efficacy, to a
greater extent than the control group. The research results are more divided for MI
and counseling interventions. In regard to the former, MI was typically found to be as
effective as standard care on HbA1c levels and diabetes-related behaviors such as diet
and physical activity in patients from Malaysia and parts of Europe (average ages 55
to 64 years old). However, when delivered in a telephone- or web-based format, MI
had the added benefits of improving diabetes-related behaviors, such as dietary
changes and physical activity, as well as psychological variables, including lowering
depression and increasing well-being and diabetes-related knowledge. Notably, this
was true in both men and women from diverse backgrounds (i.e., Arab and German).
Recent findings for counseling intervention have been mixed whereby culture-
specific counseling appears to be more effective at reducing HbA1c levels than infor-
mational booklets for middle-aged (M = 53.5 years old) Arab patients. But counseling
was no more effective than usual care for diabetes mellitus self-management in older
(M = 64.5 years old) Danish patients on improving HbA1c levels.
Commonly used psychotherapeutic interventions, such as mindfulness-based
therapies and CBT, have empirical support in recent studies for use in the manage-
ment of T2DM. This provides an evidence base for the widespread implementation
of these treatments by healthcare professionals in their care of patients with T2DM.
Training in both of these psychotherapy approaches for health professionals is
widely available through professional development workshops or training manuals,
and many workshops have been offered remotely during the COVID-19 pandemic.
In addition, the recent promising findings from a study of self-directed mindfulness
therapy suggests that healthcare professionals can recommend these programs to
patients to pursue as a self-help resource, which reduces the potential obstacles of
cost and geographic accessibility. Additional research is necessary to understand the
efficacy of counseling and alternative-format CBT before practitioners should
recommend these interventions in the management of T2DM.
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This chapter reveals that psychotherapeutic interventions are an appropriate
treatment modality for patients with T2DM and some have support from recent
studies in improving health outcomes. These interventions extend beyond treating
the physiological concerns of this disorder and can address other psychosocial vari-
ables, such as thoughts, feelings, and behaviors related to diabetes mellitus care. As
such, not only did HbA1c levels improve in a number of treatments, research has
supported changes in diet, physical activity, diabetes-related knowledge, and, in
some cases, mood. There are no known negative effects of psychotherapeutic inter-
ventions on the health or well-being of patients with T2DM. The evidence for these
interventions should be considered in regard to the sample population and size,
comparison group, length of intervention, and geographic region.
There are still many gaps in the literature regarding which groups of individuals
benefit the most from psychotherapy for T2DM and from which approach. Future
research should continue to explore psychotherapeutic interventions especially in
the areas of counseling and new delivery formats of CBT to expand treatment
options. Of note, a recent RCT of Acceptance and Commitment Therapy for
patients with T2DM has demonstrated preliminary success in improving HbA1c
levels compared to education alone [27], but more research is needed on this
intervention strategy before drawing generalized conclusions. In addition, more
attention in future research studies needs to be paid to how different types of
patients respond to psychotherapy and whether variables such as age, sex, and
ethnicity interact with intervention type to produce different outcomes. Across all
psychotherapeutic treatment modalities under investigation for use in the manage-
ment of T2DM, treatment matching research is warranted to determine which
patients may be able to benefit from modified, more accessible and cost-effective
(self-help, web-based) formats. With that more targeted research in future
research, healthcare professionals can feel even more confident implementing some
therapies, such as mindfulness-based therapies, CBT, and some formats of MI, to
promote better glycemic control and psychological well-being in their patients with
T2DM.
4. Conclusions
Psychological interventions can lower HbA1c levels, improve psychological
distress, and support healthy coping among patients with T2DM. There is recent
and reliable research support for mindfulness-based therapies at improving HbA1c
levels, blood sugar, and psychosocial variables. Results are promising, but more
research is needed on the efficacy of longer-term culture-sensitive counseling as
well as alternative delivery formats of cognitive-behavioral therapy on health
outcomes among patients with T2DM.
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Appendix: Search Strategy
To identify relevant studies, the authors used the same search terms as two
previously published systematic reviews of psychotherapy for T2DM [4, 5]. The
search was conducted by pairing relevant search terms, including “psychotherapy”,
“cognitive-behavioral therapy”, “motivational interviewing”, “counseling”, “sup-
portive therapy”, and “mindfulness-based therapy”, with “type 2 diabetes” and
“randomized controlled trial” on PsycINFO, PubMed, and Medline using a Boolean
“AND”. The search was limited to articles published after December 2012 since this
was the end of the period reviewed since the last review paper [5]. The original
search was conducted on January 24th, 2019, then repeated at each revision, on
March 24th, 2019, October 28th, 2019, and November 12th, 2020, to be thorough.
The initial search identified 268 articles. After duplicates across search engines were
removed, articles were screened by the primary author based on titles and abstracts.
For the screening process, full articles were retrieved and reviewed to confirm
relevance and eligibility. The primary author extracted data on intervention type,
methods, and outcomes. To be included in this review, the article must have been
an RCT that examined a psychotherapeutic intervention for participants who met
criteria for T2DM at the time of recruitment and must have changes in HbA1c levels
as a health outcome. Only RCT’s were reviewed so as to include only the most
scientifically rigorous research on this topic. Studies that used only pharmacological
interventions were not included. In addition, interventions that specifically targeted
comorbid disorders (e.g., depression in individuals with T2DM) and studies that
were not reported in English were also excluded from this review. In the end, 16
articles remained and were reviewed.
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